BOOKMARK
  • Korean|
  • Chinese|
  • Japanese|
  • Vietnamese
본문내용 바로가기

Aju Business Daily

SEARCH
  • ECONOMY
  • ENTERTAINMENT
  • IT
  • South Korea
  • North Korea
  • WORLD
  • SPORTS
  • LIFESTYLE
  • AUTO MOTIVE
  • OPINION
  • PEOPLE
  • MILITARY
Home > Health > article

Canada approves Celltrion's subcutaneous injection for rheumatoid arthritis indication

Lim Chang-won Reporter(cwlim34@ajunews.com) | Posted : Febuary 1, 2021, 14:33 | Updated : Febuary 1, 2021, 14:33
  • 트위터
  • 페이스북
  • 웨이보
 

[Courtesy of Celltrion]


SEOUL -- Celltrion's Remsima SC, the subcutaneous injection of Remsima, a copy of Janssen Biotech's Remicade treating rheumatoid arthritis and Crohn's disease, has secured approval from Canada's state health watchdog. Celltrion saw the green light as a bridgehead for its entry into the United States. Remsima SC can be injected into the fat layer beneath the skin at home.

Celltrion, a leading biosimilar manufacturer in South Korea, said on February 1 that Health Canada has approved Remsima SC's sales for rheumatoid arthritis indication. The company would apply for permission for inflammatory bowel disease indication later.

Infliximab is the basic ingredient of Remsima. In August 2020, Celltrion signed a joint development agreement with Intract Pharma, a British bio company, to develop oral infliximab in the form of pills. The target of Remsima SC is patients who are forced to move on to expensive secondary treatments due to resistance.

Celltrion has said that Remsima SC would increase its global presence rapidly because medical staff's preference for infliximab prescription is high in the field of inflammatory bowel disease. With Remsima SC, Celltrion has adopted an aggressive strategy to secure profitability and price penetration in competition with other subcutaneous-type products such as Adalimumab sold under the brand name of Humira, which is on the World Health Organization's list of essential medicines.

  • Lim Chang-won Reporter
  • email : cwlim34@ajunews.com
© Aju Business Daily & www.ajunews.com Copyright: All materials on this site may not be reproduced, distributed, transmitted, displayed, published or broadcast without the authorization from the Aju News Corporation.
  • twitter
  • facebook
  • weibo
  • link copy
  • LIST
  • TOP

Related news

  • .Celltrion teams up with British bio company to develop oral infliximab.
    Celltrion teams up with British bio company to develop oral …
  • .Remsima SC wins approval for additional indications in Europe.
    Remsima SC wins approval for additional indications in Europ…
  • .Celltrion aims to become global pharmaceutical company through deal with Takeda.
    Celltrion aims to become global pharmaceutical company throu…
  • .Celltrion acquires European approval to sell Remsima SC for treatment of rheumatoid arthritis.
    Celltrion acquires European approval to sell Remsima SC for …

Real Time Photo News

  • .BTS agency posts record earnings in 2020 on brisk online activities and album sales .

    BTS agency posts record earnings in 2020 on brisk online activities and album sales

  • .[FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene.

    [FOCUS] BTS agency leagues with Universal Music to launch new K-pop band in US music scene

  • .CJ ENM aims to become major visual content producer thru partnership with Epic Games .

    CJ ENM aims to become major visual content producer thru partnership with Epic Games

  • .​Solo singer Sunmi to come back with new album Tail.

    ​Solo singer Sunmi to come back with new album 'Tail'

  • .Big Hits live-streaming joint venture gains reinforcements from Universal Music, YG.

    Big Hit's live-streaming joint venture gains reinforcements from Universal Music, YG

Latest News

more+

  • Prime Minister Chung stresses importance of 'borderless communication channel' to minimize informati…
  • State hospital succeeds in inserting wireless pacemakers into hearts of bradyarrhythmia patients
  • LG Electronics' joint venture with Canada's Magna awaits approval by shareholders in March
  • Sajo Seafood to launch raw tuna menu delivery service
  • Researchers find new roundworm species near Dokdo
Aju Business Daily
  • ABOUT US
  • CONTACT US
  • PRIVACY STATEMENT
  • Copyright Policy

Address : Aju News Corporation LEEMA Building, 11th floor, 42, Jong-ro 1-gil, Jongno-gu, Seoul.    Mail : swatchsjp@ajunews.com

Copyright ⓒ 2016 By Ajunews Corporation, All Rights Reserved.

Mobile view